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INCIDENCE OF INTERMEDIATE SYNDROME IN PATIENTS 
ADMITTED IN TVMCH FOLLOWING ORGANOPHOSPHATE 
POISONING 
INTRODUCTION 
                  Organophosphate poisoning remains a major cause for morbidity and 
mortality in various areas of Tamil Nadu. OPC poisoning can manifest in three 
different clinical phases namely: Acute cholinergic crisis within few minutes to 
several hours, Intermediate syndrome and Delayed polyneuropathy 2-3 weeks 
after acute exposure. First described by Senanayake and Karallede in 1987, 
intermediate syndrome is characterised by weakness of proximal limb muscles; 
neck flexors; respiratory muscles; motor cranial nerves. Atypical presentation 
includes continued or relapse of acute cholinergic crisis. Prompt identification 
and management could decrease the morbidity and mortality. 
AIM OF THE STUDY: To document the clinical profile, the laboratory profile 
and to study the incidence of intermediate syndrome in patients admitted with 
organophosphate poisoning in TVMCH from January 2016 to January 2017. 
MATERIALS AND METHODOLOGY: 75 randomly selected patients 
admitted in the Department of Medicine, Tirunelveli medical college hospital 
from January 2016 to January 2017 were studied. Patients who qualified the 
inclusion criteria of this study were followed up from admission till the end point 
(discharge/death). The type of OPC consumed, their clinical profile and 
laboratory profile were documented in predesigned data collection forms. 
RESULTS: The mortality due to OPC poisoning in this study was 20%. The 
incidence of intermediate syndrome in this study was 12%. The occurrence of 
intermediate syndrome was more frequent in Dimethoate compound. The serum 
cholinesterase level was significantly lower in those patients who required 
ventilator support. The serum cholinesterase level was significantly lower in the 
patients who died when compared to those who survived. Hence low serum 
cholinesterase level was associated with increased mortality. 
CONCLUSION: The incidence of intermediate syndrome in this study was 12%, 
with Dimethoate being the most common OP compound responsible. 
Intermediate syndrome is an important complication of OPC poisoning and 
should be treated adequately. Complete recovery from skeletal muscle weakness 
occurs in IMS, provided ventilatory care is adequate. Therefore the treating 
physician has to be watchful for the development of intermediate syndrome, as 
early recognition and management provides good survival benefit. 
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